Methylprednisolone Orion (Methylprednisolone)

• Methylprednisolone acts on inflammatory and immune pathways to control severe allergic and autoimmune conditions.
• Severe allergic reactions: rapidly diminishes airway swelling and systemic inflammation.
• Asthma exacerbations: improves lung function by decreasing airway edema and hyper‑responsiveness.
• Rheumatoid arthritis: lessens joint pain and swelling by inhibiting cytokine production.
• Dermatologic inflammatory disorders: reduces skin lesion redness and itching.
• Multiple sclerosis relapses: shortens relapse duration by modulating immune activity.
• Acute inflammatory conditions: provides prompt symptom relief in various organ systems.

• Methylprednisolone is a synthetic glucocorticoid that diffuses across cell membranes and binds intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it binds glucocorticoid response elements and alters gene transcription, suppressing pro‑inflammatory cytokines, chemokines, and adhesion molecules while up‑regulating anti‑inflammatory proteins.

Methylprednisolone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Increased appetite or weight gain.
• Elevated blood glucose levels.
• Mood changes, including anxiety or insomnia.
• Gastrointestinal discomfort or ulcer risk.
• Fluid retention leading to mild edema.

Serious or Rare Side Effects

• Severe infections due to immunosuppression.
• Osteoporosis or bone fractures with prolonged use.
• Adrenal insufficiency on abrupt discontinuation.
• Vision problems such as cataracts or glaucoma.
• Allergic reactions including rash or anaphylaxis.

• Before initiating therapy, consider patient‑specific factors and monitor for complications.
• Assess infection risk: avoid use in active, uncontrolled infections.
• Screen for diabetes: monitor blood glucose regularly.
• Evaluate bone health: consider calcium and vitamin D supplementation for long‑term therapy.
• Monitor psychiatric status: watch for mood swings or depression.
• Avoid abrupt cessation: taper dose to prevent adrenal crisis.
• Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Methylprednisolone can alter the effectiveness or safety of several co‑administered drugs.

Major Interactions (Avoid)

• Live vaccines: may cause uncontrolled infection.
• Strong CYP3A4 inducers (e.g., rifampicin): can reduce steroid levels.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal bleeding.
• Anticoagulants (warfarin): may enhance anticoagulant effect.
• Diabetic medications: may require dose adjustment due to hyperglycaemia.